Long-term Outcomes of Early Use of Long-Acting Injectable Antipsychotics in Schizophrenia

For anyone that doesn’t want to read:

Conclusions: Switching to LAIs during the first 3 years of treatment improved antipsychotic adherence, decreased relapses, and reduced long-term mortality. Our results provide evidence to support the benefits of early LAI treatment in schizophrenia.

1 Like